Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF

被引:50
作者
Fasouliotis, SJ [1 ]
Laufer, N [1 ]
Sabbagh-Ehrlich, S [1 ]
Lewin, A [1 ]
Hurwitz, A [1 ]
Simon, A [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Obstet & Gynecol, IVF Unit, IL-91120 Jerusalem, Israel
关键词
cetrorelix; GnRH-agonist; GnRH-antagonist; IVF; poor responders;
D O I
10.1023/B:JARG.0000006707.88826.e7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: The objective of this study was to compare the efficacy of GnRH-antagonists to GnRH-agonists in ovarian stimulation of poor responders undergoing IVF. Methods: Retrospective analysis of our data revealed that 56 patients underwent treatment with a GnRH-agonist according to the flare-up protocol. Patients failing to achieve an ongoing pregnancy (n = 53) were subsequently treated in the next cycle with a GnRH- antagonist according to the multiple-dose protocol. Main outcome measures included the clinical pregnancy and implantation rates. Results: While ovulation induction characteristics and results did not differ between the two protocols, the number of embryos transferred was significantly higher (P = 0.046) in the GnRH- antagonist than in the GnRH-agonist stimulation protocol (2.5 +/- 1.6 vs. 2.0 +/- 1.4, respectively). The clinical pregnancy and implantation rates per transfer in the GnRH- antagonist group appeared higher than in the GnRH- agonist, but did not differ statistically (26.1 and 10.7 compared with 12.2 and 5.9%, respectively). However, the ongoing pregnancy rate per transfer was statistically significantly higher (P = 0.03) in the GnRH- antagonist than in the GnRH- agonist group (23.9 vs. 7.3%, respectively). Conclusion: Applying GnRH- antagonists to ovarian stimulation protocols may offer new hope for IVF poor responder patients. However, further controlled randomized prospective studies with larger sample sizes are required to establish these results.
引用
收藏
页码:455 / 460
页数:6
相关论文
共 20 条
  • [1] Addition of GnRH antagonist in cycles of poor responders undergoing IVF
    Akman, MA
    Erden, HF
    Tosun, SB
    Bayazit, N
    Aksoy, E
    Bahceci, M
    [J]. HUMAN REPRODUCTION, 2000, 15 (10) : 2145 - 2147
  • [2] Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial
    Akman, MA
    Erden, HF
    Tosun, SB
    Bayazit, N
    Aksoy, E
    Bahceci, M
    [J]. HUMAN REPRODUCTION, 2001, 16 (05) : 868 - 870
  • [3] BENRAFAEL Z, 1991, FERTIL STERIL, V55, P272
  • [4] Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols?
    Craft, I
    Gorgy, A
    Hill, J
    Menon, D
    Podsiadly, B
    [J]. HUMAN REPRODUCTION, 1999, 14 (12) : 2959 - 2962
  • [5] Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders
    Faber, BM
    Mayer, J
    Cox, B
    Jones, D
    Toner, JP
    Oehninger, S
    Muasher, SJ
    [J]. FERTILITY AND STERILITY, 1998, 69 (05) : 826 - 830
  • [6] Evaluation and treatment of low responders in assisted reproductive technology: A challenge to meet
    Fasouliotis, SJ
    Simon, A
    Laufer, N
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2000, 17 (07) : 357 - 373
  • [7] FELDBERG D, 1994, FERTIL STERIL, V62, P343
  • [8] LEUNG PCK, 1999, GYNAECOL ENDOCRINOL, V13, P10
  • [9] A new indication for an intracytoplasmic sperm injection procedure outside the cases of severe male factor infertility
    Ludwig, M
    Al-Hasani, S
    Küpker, W
    Bauer, O
    Diedrich, K
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1997, 75 (02): : 207 - 210
  • [10] Mannaerts B, 1998, HUM REPROD, V13, P3023